Built on relationships. Backed by results. The Alliance for Multispecialty Research (AMR) is a clinical research company of 16 of the most highly experienced clinical research centers in the U.S. Over the past 23 years, AMR centers have enrolled over 145,000 subjects and completed more than 9,500 Phase I-IV clinical trials across a broad range of therapeutic areas, including studies evaluating pharmacokinetics, pharmacodynamics, and bioequivalent/bioavailability. AMR’s combined internal database of over 225,000 potential study volunteers, along with our physician databases of more than 1.3 million patients, allow us to perform detailed searches to promptly identify prospective subjects. Our proven experience, streamlined processes, and vast resources empower us to consistently meet or exceed study enrollment targets. We employ intentional strategies designed to optimize enrollment and retention, resulting in an average enrollment rate of more than 110%, and an average retention rate of more than 92% for general out-patient studies and more than 96% for vaccine-specific trials. AMR offers flexible solutions tailored to each protocol’s unique requirements. We can coordinate multi-center studies through centralized processes, maximizing economies of scale and minimizing timeframes to best serve our clients by using single-point-of-contact communication and standardization of study budgets, contracts, payments, and source documents. Centralization results not only in shortened timelines and increased savings to our clients, but also enables sponsors and CROs to engage multiple centers simultaneously instead of dealing with each center on an individual basis. However, AMR also offers sponsors and CRO’s a direct-to-site options, allowing companies to contract directly with individual locations.